THE CONAFAY GROUP, LLC

Lobbying for CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP · Representing the voice of emerging antibiotics industry

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · North Carolina · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Legislation related to antimicrobial resistance(AMR), reimbursement reform, CURES Act 2.0 and FY26 Appropriations and PAHPA.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.